CBD pre-treatment could exacerbate side effects

A significant proportion of people with schizophrenia use cannabis, with around one in five meeting the criteria for a comorbid cannabis use disorder, for which there are still limited effective and targeted treatment options. With this in mind, researchers in the UK investigated whether pre-treatment with cannabidiol (CBD) could mitigate the acute cognitive and psychotic side effects of cannabis in this patient group.